Progress in Biomaterials, volume 8, issue 3, pages 155-168

Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles

Publication typeJournal Article
Publication date2019-06-13
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor4.9
ISSN21940509, 21940517
General Medicine
Abstract
Active targeting of folic acid and passive targeting of magnetic nanoparticles to bring about co-delivery of hydrophobic chemotherapeutic agents were the focus of this work. Co-precipitation in alkaline environment was employed for synthesizing Fe3O4 nanoparticles and stabilized by oleic acid. Aqueous dispersibility of oleic acid coated nanoparticles was brought about by folic acid modified Pluronic F127 and Pluronic F127 mixture. Folic acid is used as a targeting agent which was joined to Pluronic F127 via diethylene glycol bis(3-aminopropyl) ether spacer. The nanocomposite was used to delivery hydrophobic anticancer drugs, paclitaxel, and curcumin. Successful modification at each step was confirmed by FTIR and NMR. Quantitative analysis of attached folic acid indicated a total of 84.34% amount of conjugation. Nanoparticles characterization revealed the hydrodynamic size of and nanocomposite to be 94.2 nm nanometres. Furthermore, transmission electron micrograph reveals the size of the nanoparticle to be 12.5 nm hence also shows the superparamagnetic activity. Drug encapsulation efficiency of 34.7% and 59.5% was noted for paclitaxel and curcumin, respectively. Cytotoxic property of drug-loaded nanocomposites was increased in case of folic acid functionalized nanoparticles and further increased in the presence of an external magnetic field. Cellular uptake increased in the folic acid conjugated sample. Further many folds in the presence of an external magnetic field.Graphic abstract

Citations by journals

1
2
Pharmaceutics
Pharmaceutics, 2, 6.45%
Pharmaceutics
2 publications, 6.45%
Pharmaceutical Chemistry Journal
Pharmaceutical Chemistry Journal, 1, 3.23%
Pharmaceutical Chemistry Journal
1 publication, 3.23%
Frontiers in Pharmacology
Frontiers in Pharmacology, 1, 3.23%
Frontiers in Pharmacology
1 publication, 3.23%
Nanomaterials
Nanomaterials, 1, 3.23%
Nanomaterials
1 publication, 3.23%
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology, 1, 3.23%
Frontiers in Bioengineering and Biotechnology
1 publication, 3.23%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 3.23%
Journal of Nanobiotechnology
1 publication, 3.23%
Journal of Nanoparticle Research
Journal of Nanoparticle Research, 1, 3.23%
Journal of Nanoparticle Research
1 publication, 3.23%
Journal of Solid State Electrochemistry
Journal of Solid State Electrochemistry, 1, 3.23%
Journal of Solid State Electrochemistry
1 publication, 3.23%
Chemico-Biological Interactions
Chemico-Biological Interactions, 1, 3.23%
Chemico-Biological Interactions
1 publication, 3.23%
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces, 1, 3.23%
Colloids and Surfaces B: Biointerfaces
1 publication, 3.23%
Biomedical Materials (Bristol)
Biomedical Materials (Bristol), 1, 3.23%
Biomedical Materials (Bristol)
1 publication, 3.23%
Materials Today Bio
Materials Today Bio, 1, 3.23%
Materials Today Bio
1 publication, 3.23%
Life Sciences
Life Sciences, 1, 3.23%
Life Sciences
1 publication, 3.23%
Materials Science and Engineering C
Materials Science and Engineering C, 1, 3.23%
Materials Science and Engineering C
1 publication, 3.23%
Colloids and Surfaces A: Physicochemical and Engineering Aspects
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 1, 3.23%
Colloids and Surfaces A: Physicochemical and Engineering Aspects
1 publication, 3.23%
Journal of Controlled Release
Journal of Controlled Release, 1, 3.23%
Journal of Controlled Release
1 publication, 3.23%
Macromolecular Chemistry and Physics
Macromolecular Chemistry and Physics, 1, 3.23%
Macromolecular Chemistry and Physics
1 publication, 3.23%
RSC Advances
RSC Advances, 1, 3.23%
RSC Advances
1 publication, 3.23%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 1, 3.23%
Journal of Materials Chemistry B
1 publication, 3.23%
Pharmaceutical Development and Technology
Pharmaceutical Development and Technology, 1, 3.23%
Pharmaceutical Development and Technology
1 publication, 3.23%
Drug Delivery
Drug Delivery, 1, 3.23%
Drug Delivery
1 publication, 3.23%
Particuology
Particuology, 1, 3.23%
Particuology
1 publication, 3.23%
Drug Development Research
Drug Development Research, 1, 3.23%
Drug Development Research
1 publication, 3.23%
Materials
Materials, 1, 3.23%
Materials
1 publication, 3.23%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 1, 3.23%
Biomedicine and Pharmacotherapy
1 publication, 3.23%
Nanomedicine and Nanotoxicology
Nanomedicine and Nanotoxicology, 1, 3.23%
Nanomedicine and Nanotoxicology
1 publication, 3.23%
International Journal of Nanomedicine
International Journal of Nanomedicine, 1, 3.23%
International Journal of Nanomedicine
1 publication, 3.23%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 1, 3.23%
International Journal of Biological Macromolecules
1 publication, 3.23%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 1, 3.23%
Journal of Drug Delivery Science and Technology
1 publication, 3.23%
1
2

Citations by publishers

2
4
6
8
10
12
Elsevier
Elsevier, 11, 35.48%
Elsevier
11 publications, 35.48%
Springer Nature
Springer Nature, 5, 16.13%
Springer Nature
5 publications, 16.13%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 4, 12.9%
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 12.9%
Frontiers Media S.A.
Frontiers Media S.A., 2, 6.45%
Frontiers Media S.A.
2 publications, 6.45%
Wiley
Wiley, 2, 6.45%
Wiley
2 publications, 6.45%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 6.45%
Royal Society of Chemistry (RSC)
2 publications, 6.45%
Taylor & Francis
Taylor & Francis, 2, 6.45%
Taylor & Francis
2 publications, 6.45%
IOP Publishing
IOP Publishing, 1, 3.23%
IOP Publishing
1 publication, 3.23%
Dove Medical Press
Dove Medical Press, 1, 3.23%
Dove Medical Press
1 publication, 3.23%
2
4
6
8
10
12
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Hiremath C. G. et al. Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles // Progress in Biomaterials. 2019. Vol. 8. No. 3. pp. 155-168.
GOST all authors (up to 50) Copy
Hiremath C. G., Heggnnavar G. B., Kariduraganavar M. Y., Hiremath M. B. Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles // Progress in Biomaterials. 2019. Vol. 8. No. 3. pp. 155-168.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s40204-019-0118-5
UR - https://doi.org/10.1007%2Fs40204-019-0118-5
TI - Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
T2 - Progress in Biomaterials
AU - Hiremath, Chinmay G
AU - Heggnnavar, Geetha B
AU - Kariduraganavar, Mahadevappa Y
AU - Hiremath, Murigendra B.
PY - 2019
DA - 2019/06/13 00:00:00
PB - Springer Nature
SP - 155-168
IS - 3
VL - 8
PMID - 31197663
SN - 2194-0509
SN - 2194-0517
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Hiremath,
author = {Chinmay G Hiremath and Geetha B Heggnnavar and Mahadevappa Y Kariduraganavar and Murigendra B. Hiremath},
title = {Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles},
journal = {Progress in Biomaterials},
year = {2019},
volume = {8},
publisher = {Springer Nature},
month = {jun},
url = {https://doi.org/10.1007%2Fs40204-019-0118-5},
number = {3},
pages = {155--168},
doi = {10.1007/s40204-019-0118-5}
}
MLA
Cite this
MLA Copy
Hiremath, Chinmay G., et al. “Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles.” Progress in Biomaterials, vol. 8, no. 3, Jun. 2019, pp. 155-168. https://doi.org/10.1007%2Fs40204-019-0118-5.
Found error?